Report Overview
Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
www.reallygreatsite.com
Market Share
The global Japanese Encephalitis Vaccines market size was estimated at USD 208.60 million in 2023 and is projected to reach USD 332.02 million by 2032, exhibiting a CAGR of 5.30% during the forecast period.
North America Japanese Encephalitis Vaccines market size was estimated at USD 59.41 million in 2023, at a CAGR of 4.54% during the forecast period of 2025 through 2032.
Key Company
• Sanofi Pasteur
• GlaxoSmithKline
• Bharat Biotech
• China National Biotec Group
• Valneva Products
Market Segmentation
• Attenuated Vaccines
• Inactivated Vaccines
By Application
• Adults
• Children
Geographic Segmentation
•North America: USA, Canada, Mexico
•Europe: Germany, UK, France, Russia, Italy, Rest of Europe
•Asia-Pacific: China, Japan, South Korea, India, SoutheastAsia, Rest ofAsia-Pacific
•South America: Brazil, Argentina, Colombia, Rest of SouthAmerica
•Middle East and Africa: Saudi Arabia, UAE, Egypt, Nigeria, SouthAfrica, Rest of MEA
